A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes

<table>Schematic of CNTO 530. The schematic outlines the structure of CNTO 530 including the engineered Fc (CH2 and CH3 domains), a linker containing a partial VH region, and two EMP-1 peptides.</table>

Journal of Diabetes Research

fig1

Figure 1

Figure 1: A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes 